Altogether, our data suggest that neuroblastoma cells are sensitive to lower and higher PLK4i concentrations in two distinct ways: at lower doses, neuroblastoma cells are killed by PLK4i regardless of TRIM37 and TP53 status, whereas at higher doses neuroblastoma sensitivity depends on high TRIM37 and functional p53. The gene discussed is TP53; the disease is neuroblastoma.